FDA Inspection 801737 — Janssen Biotech, Inc.
The FDA completed an inspection of Janssen Biotech, Inc. on Sep 25, 2012 in Malvern, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 25, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Malvern, PA (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)